schizophrenia
Conditions
Interventions
magnetic resonance imaging, blood sampling
magnetic resonance imaging
Sponsors
The Jikei University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: <schizophrenia> 1. Patients with schizophrenia diagnosed by DSM-IV-TR taking risperiodone 2. over 20 years old, less than 50 years old 3. male and female 4. Those who can read and understand informed consent of the protocol 5. Those who are treated by risperidone 6. Those who do not take benzadiazepines <healthy control> 1. Those who do not have psychiatric/severe physical disease 2. over 20 years old, less than 50 years old 3. male and female
Exclusion criteria
Exclusion criteria: <schizophrenia> 1. Those who have severe psychiatric symptom 2. Those who have other psychiatric disorder(s) 3. Those who have organic brain disease 4. Those who have severe physical disease 5. Those who pregnant or have a possibility of pregnancy 6. Those who have heart pace maker or other metal in their body 7. Those who have agrophobia 8. Those who have tatoo 9. Those who are considered as not eligible by principal investigator <healthy control> 1.Those who pregnant or have a possibility of pregnancy 2. Those who have heart pace maker or other metal in their body 3. Those who have agrophobia 4. Those who have tatoo 5. Those who are considered as not eligible by principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relationship between functional connectivity in salience network and D2/3 receptor occupancy by risperidone in patients with schizophrenia. | — |
Countries
Japan
Contacts
Public ContactKodaka Fumitoshi
The Jikei University School of Medicine Department of Psychiatry
Outcome results
None listed